Literature DB >> 21703181

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

Judith Aron-Wisnewsky1, Caroline Minville, Joan Tordjman, Patrick Lévy, Jean-Luc Bouillot, Arnaud Basdevant, Pierre Bedossa, Karine Clément, Jean-Louis Pépin.   

Abstract

BACKGROUND & AIMS: Morbid obesity is frequently associated with low grade systemic inflammation, increased macrophage accumulation in adipose tissue (AT), obstructive sleep apnea (OSA), and nonalcoholic fatty liver disease (NAFLD). It has been suggested that chronic intermittent hypoxia (CIH) resulting from OSA could be an independent factor for early stage of NAFLD in addition to other well-recognized factors (dyslipidemia or insulin resistance). Moreover, macrophage accumulation in AT is associated with local hypoxia in fat tissue. We hypothesized that the association between CIH and morbid obesity could exert additional specific deleterious effects both in the liver and adipose tissues.
METHODS: One hundred and one morbidly obese subjects were prospectively recruited and underwent bariatric surgery during which a liver needle biopsy as well as surgical subcutaneous and omental AT biopsies were obtained. Oxygen desaturation index (ODI) quantified the severity of nocturnal CIH.
RESULTS: Histopathologic analysis of liver biopsies demonstrated that NAFLD lesions (ballooning of hepatocytes, lobular inflammation), NAFLD activity score (NAS), and fibrosis were significantly more severe in patients with the highest ODI tertile (p values ≤0.001 for all hepatic lesions). In multivariate analysis, after adjustment for age, obesity, and insulin resistance status, CIH remained independently associated with hepatic fibrosis, fibroinflammation, and NAS. By contrast, no association was found between CIH, macrophage accumulation, and adipocytes size in both subcutaneous and omental adipose tissue.
CONCLUSIONS: In morbidly obese patients, CIH was strongly associated with more severe liver injuries but did not worsen obesity induced macrophage accumulation in adipose tissue depots.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703181     DOI: 10.1016/j.jhep.2011.04.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  83 in total

1.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

2.  Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.

Authors:  Jia-Chao Qi; Jian-Chai Huang; Qi-Chang Lin; Jian-Ming Zhao; Xin Lin; Li-Da Chen; Jie-Feng Huang; Xiao Chen
Journal:  Sleep Breath       Date:  2015-07-15       Impact factor: 2.816

3.  Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.

Authors:  Kathleen E Corey; Joseph Misdraji; Lou Gelrud; Lindsay Y King; Hui Zheng; Atul Malhotra; Raymond T Chung
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 4.  Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.

Authors:  Silke Ryan
Journal:  J Physiol       Date:  2017-01-25       Impact factor: 5.182

Review 5.  Obstructive Sleep Apnea and the Liver.

Authors:  Malav P Parikh; Niyati M Gupta; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2019-05       Impact factor: 6.126

6.  The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.

Authors:  Sylvie Naveau; Karima Lamouri; Guillaume Pourcher; Micheline Njiké-Nakseu; Stefano Ferretti; Rodi Courie; Hadrien Tranchart; Mariana Ghinoiu; Axel Balian; Sophie Prévot; Gabriel Perlemuter; Ibrahim Dagher
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

7.  Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.

Authors:  Donghee Kim; Aijaz Ahmed; Clete Kushida
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

8.  Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ronald J Sokol; Kelley E Capocelli; Zhaoxing Pan; Jillian S Sullivan; Kristen Robbins; Ann C Halbower
Journal:  J Pediatr       Date:  2013-12-07       Impact factor: 4.406

Review 9.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Obesity: CPAP effects in sleep apnoea-what should be expected?

Authors:  Patrick Lévy; Jean-Louis Pépin
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.